{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:09:59Z","timestamp":1792976999072,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["2KL2TR002547"],"award-info":[{"award-number":["2KL2TR002547"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019510","name":"Omeros Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jtct.2022.07.020","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T20:31:17Z","timestamp":1658781077000},"page":"737-746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-2881","authenticated-orcid":false,"given":"Jane","family":"Koo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1515-2141","authenticated-orcid":false,"given":"Jeffrey J.","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-2538","authenticated-orcid":false,"given":"David M.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6579-6714","authenticated-orcid":false,"given":"John","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Jaglowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katilyn","family":"Kusnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1732-6694","authenticated-orcid":false,"given":"Joseph","family":"Maakaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahna","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2869-0432","authenticated-orcid":false,"given":"Loretta","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6041-5265","authenticated-orcid":false,"given":"Rachel","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Sper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Rotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Dandoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.07.020_bib0001","unstructured":"World health Organization (WHO). WHO coronavirus (COVID-19) dashboard. Available at: https:\/\/covid19.who.int\/. Published 2022. Accessed March 1, 2022."},{"key":"10.1016\/j.jtct.2022.07.020_bib0002","article-title":"COVID Data Tracker","year":"2022","journal-title":"Trends in number of COVID-19 cases and deaths in the US reported to CDC, by state\/territory"},{"key":"10.1016\/j.jtct.2022.07.020_bib0003","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtct.2022.07.020_bib0004","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bbmt.2015.07.032","article-title":"Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"21","author":"Majhail","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.07.005","article-title":"Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients","volume":"27","author":"Mushtaq","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0006","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.bbmt.2020.07.021","volume":"26","author":"Algwaiz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0007","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2022.07.020_bib0008","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41375-021-01302-5","article-title":"COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey","volume":"35","author":"Ljungman","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.07.020_bib0009","doi-asserted-by":"crossref","first-page":"e28557","DOI":"10.1002\/pbc.28557","article-title":"Initial report on Spanish pediatric oncologic, hematologic, and post stem cell transplantation patients during SARS-CoV-2 pandemic","volume":"67","author":"Faura","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2022.07.020_bib0010","doi-asserted-by":"crossref","first-page":"756","DOI":"10.7326\/M20-1133","article-title":"A war on two fronts: cancer care in the time of COVID-19","volume":"172","author":"Kutikov","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.07.020_bib0011","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.bbmt.2020.04.018","article-title":"Addressing the impact of the coronavirus disease 2019 (COVID-19) pandemic on hematopoietic cell transplantation: learning networks as a means for sharing best practices","volume":"26","author":"Ardura","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0012","unstructured":"The New York Times. Coronavirus (Covid-19) data in the United States. Available at: https:\/\/github.com\/nytimes\/covid-19-data. Accessed May 22, 2022."},{"key":"10.1016\/j.jtct.2022.07.020_bib0013","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41409-020-01068-x","article-title":"Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach","volume":"56","author":"Ueda Oshima","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.02.011","article-title":"Cellular therapy during COVID-19: lessons learned and preparing for subsequent waves","volume":"27","author":"Nawas","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41409-021-01483-8","article-title":"Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT","volume":"57","author":"Ghorashian","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0016","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.bbmt.2020.07.027","article-title":"Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients","volume":"26","author":"Waghmare","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0017","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2021-152952","article-title":"Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: a report from the National Marrow Donor Program","volume":"138","author":"Stefanski","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.020_bib0018","first-page":"84","article-title":"Impact of COVID-19 on peripheral stem cell collection and preservation at a hematopoietic cell transplant center in India: Experience 2020","volume":"4","author":"Javed","year":"2021","journal-title":"Blood Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0019","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1038\/s41409-021-01287-w","article-title":"Changes in stem cell transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)","volume":"56","author":"Russo","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2020.11.019","article-title":"Changes in hematopoietic cell transplantation practices in response to COVID-19: a survey from the Worldwide Network for Blood & Marrow Transplantation","volume":"27","author":"Worel","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0021","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/bloodadvances.2020003883","article-title":"COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience","volume":"5","author":"Maurer","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2022.07.020_bib0022","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.30455","article-title":"Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic","volume":"3","author":"Edlow","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2022.07.020_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5045\/br.2021.2021021","article-title":"COVID-19 pandemic: a double-edged sword for cord blood banking","volume":"56","author":"Lee","year":"2021","journal-title":"Blood Res"},{"key":"10.1016\/j.jtct.2022.07.020_bib0024","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41409-021-01477-6","article-title":"Impact of COVID-19 pandemic on the use and release of cord blood units facilitated by the French Cord Blood Banks Network: on behalf of the Agency of Biomedicine, Eurocord and the French Society of Bone Marrow Transplant and Cell Therapy (SFGM-TC)","volume":"57","author":"Rafii","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0025","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/cid\/ciab534","article-title":"The effect of neutropenia and filgrastim (G-CSF) on cancer patients with coronavirus disease 2019 (COVID-19) infection","volume":"74","author":"Zhang","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jtct.2022.07.020_bib0026","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jtct.2021.03.015","article-title":"The effect of donor graft cryopreservation on allogeneic hematopoietic cell transplantation outcomes: a Center for International Blood and Marrow Transplant Research analysis. Implications during the COVID-19 pandemic","volume":"27","author":"Hsu","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0027","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ejh.13714","article-title":"Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts","volume":"108","author":"Novitzky-Basso","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.07.020_bib0028","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.bbmt.2020.04.001","article-title":"Graft cryopreservation does not impact overall survival after allogeneic hematopoietic cell transplantation using post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis","volume":"26","author":"Hamadani","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0029","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41409-021-01367-x","article-title":"Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?","volume":"56","author":"Fernandez-Sojo","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0030","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.bbmt.2020.04.027","article-title":"Hematopoietic cell transplantation with cryopreserved grafts for severe aplastic anemia","volume":"26","author":"Eapen","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0031","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jtct.2020.10.014","article-title":"Meeting the demand for unrelated donors in the midst of the COVID-19 pandemic: rapid adaptations by the National Marrow Donor Program and its network partners ensured a safe supply of donor products","volume":"27","author":"Auletta","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0032","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41409-020-01138-0","article-title":"Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS","volume":"56","author":"Mengling","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0033","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/14777509211036643","article-title":"Bone marrow donation in Poland: 2021 update, and the impact of the coronavirus disease 2019 pandemic on haematopoietic stem cell transplantation","volume":"17","author":"Janowiak-Majeranowska","year":"2022","journal-title":"Clin Ethics"},{"key":"10.1016\/j.jtct.2022.07.020_bib0034","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41409-022-01667-w","article-title":"Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-report from World Marrow Donor Association","volume":"57","author":"J\u00f6ris","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0035","first-page":"3225","article-title":"Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy","volume":"30","author":"Ambroggi","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2022.07.020_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10651","article-title":"Association of the coronavirus disease 2019 (COVID-19) outbreak with enrollment in cancer clinical trials","volume":"3","author":"Unger","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtct.2022.07.020_bib0037","unstructured":"US Food and Drug Administration. FDA guidance on conduct of clinical trials of medical products during COVID-19 public health emergency. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency. Accessed March 2, 2022."},{"key":"10.1016\/j.jtct.2022.07.020_bib0038","article-title":"Coronavirus guidance","year":"2020","journal-title":"CTEP Cancer Therapy Evaluation Program"},{"key":"10.1016\/j.jtct.2022.07.020_bib0039","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamaoncol.2020.5748","article-title":"Association of the COVID-19 outbreak with patient willingness to enroll in cancer clinical trials","volume":"7","author":"Fleury","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2022.07.020_bib0040","doi-asserted-by":"crossref","first-page":"e432","DOI":"10.1016\/S2352-3026(20)30123-X","article-title":"Effect of the COVID-19 pandemic on cancer treatment and research","volume":"7","author":"Saini","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2022.07.020_bib0041","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/cts.13177","article-title":"Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemic","volume":"15","author":"Zhu","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jtct.2022.07.020_bib0042","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jcyt.2020.12.001","article-title":"Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal","volume":"23","author":"Valentini","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jtct.2022.07.020_bib0043","series-title":"COVID-19 Rapid Guideline: Haematopoietic Stem Cell Transplantation","year":"2021"},{"key":"10.1016\/j.jtct.2022.07.020_bib0044","series-title":"Coronavirus disease COVID-19","year":"2022"},{"key":"10.1016\/j.jtct.2022.07.020_bib0045","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.bbmt.2020.02.004","article-title":"Pilot study of telehealth evaluations in patients undergoing hematopoietic cell transplantation","volume":"26","author":"Nawas","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0046","doi-asserted-by":"crossref","first-page":"e13615","DOI":"10.1200\/JCO.2021.39.15_suppl.e13615","article-title":"Telehealth to increase access to transplant survivorship care for allogeneic stem cell transplant recipients regardless of distance to transplant center or neighborhood income","volume":"39","author":"Ahmed","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.07.020_bib0047","doi-asserted-by":"crossref","first-page":"e26121","DOI":"10.2196\/26121","article-title":"Use of telehealth for domiciliary follow-up after hematopoietic cell transplantation during the COVID-19 pandemic: prospective pilot study","volume":"5","author":"Mussetti","year":"2021","journal-title":"JMIR Form Res"},{"key":"10.1016\/j.jtct.2022.07.020_bib0048","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.bbmt.2020.02.027","article-title":"Feasibility and acceptability of using a telehealth platform to monitor cardiovascular risk factors in hematopoietic cell transplantation survivors at risk for cardiovascular disease","volume":"26","author":"Chang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0049","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/trf.15789","article-title":"Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus (COVID-19) pandemic affecting Washington State","volume":"60","author":"Pagano","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2022.07.020_bib0050","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1186\/s12913-021-06917-z","article-title":"Experiences of frontline healthcare workers and their views about support during COVID-19 and previous pandemics: a systematic review and qualitative meta-synthesis","volume":"21","author":"Billings","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jtct.2022.07.020_bib0051","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.psym.2019.02.004","article-title":"Psychological considerations in hematopoietic stem cell transplantation","volume":"60","author":"Amonoo","year":"2019","journal-title":"Psychosomatics"},{"issue":"suppl 3","key":"10.1016\/j.jtct.2022.07.020_bib0052","first-page":"231","article-title":"Anxiety and depression in patients with acute leukaemia treated with hematopoietic stem cell transplantation","volume":"31","author":"Warchala","year":"2019","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.jtct.2022.07.020_bib0053","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2022.010","article-title":"Nurses' physical and psychological symptoms during the first COVID-19 lockdown in Italy: a nationwide cross-sectional study in stem cell transplantation setting","volume":"14","author":"Botti","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.jtct.2022.07.020_bib0054","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41409-022-01604-x","article-title":"Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey","volume":"57","author":"Passweg","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.020_bib0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1188\/21.CJON.457-464","article-title":"Homecare encounters: an organizational response to innovative care for patients undergoing hematopoietic stem cell transplantation during COVID-19","volume":"25","author":"Liu","year":"2021","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jtct.2022.07.020_bib0056","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ajhp\/zxab072","article-title":"Mitigating the risk of COVID-19 exposure by transitioning from clinic-based to home-based immune globulin infusion","volume":"78","author":"Perreault","year":"2021","journal-title":"Am J Health Syst Pharm"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2022.07.020_bib0057","article-title":"Cryopreservation of allogeneic hematopoietic cell grafts did not adversely affect early post-transplant survival during the first six months of the COVID-19 pandemic","volume":"138","author":"Devine","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.020_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.04.022","article-title":"Cryopreservation of unrelated hematopoietic stem cells from a blood and marrow donor bank during the COVID-19 pandemic: a nationwide survey by the Japan Marrow Donor Program","volume":"27","author":"Kanda","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2021.04.026","article-title":"Universal engraftment after allogeneic hematopoietic cell transplantation using cryopreserved CD34-selected grafts","volume":"27","author":"Jacob","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2022.07.020_bib0060","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jtct.2021.09.012","article-title":"Good engraftment but quality and donor concerns for cryopreserved hemopoietic progenitor cell products collected during the COVID-19 pandemic","volume":"27","author":"Purtill","year":"2021","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722014828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722014828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:04:58Z","timestamp":1763003098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722014828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666636722014828"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.020","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Impact of the Coronavirus Disease 19 Pandemic on Patients and the Cellular Therapy Healthcare Ecosystem","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}